Brimonidine (Brimtim 01)
Brimonidine Tartrate/timolol Maleate Ophthalmic Solution
Product Images NDC 60505-0589
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate/timolol Maleate Ophthalmic Solution (NDC 60505-0589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Timolol (Brimtim 02)
Bottle (Brimtim Bottle)
This is a description of an ophthalmic solution manufactured by Apotex Corp. The product, labeled with NDC 60505-0589-1, contains 2 mo of brimonidine tartrate and 6.8 mg of timolol maleate equivalent to 5 mg. The solution also contains preservative benzalkonium chloride (0.005%). The recommended application of the ophthalmic solution is in the eye.*
Carton (Brimtim Carton)
This is a description for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution. The solution is for topical application in the eye and it is sterile. Each bottle contains approximately 4 capacity and contains 2mg brimonidine tartrate and 68 mg timolol maleate equivalent o 5 mg timolol. The preservative used is benzalkonium chloride at 0.005% and its inactive ingredients include sodium phosphate dibasic heptahydrate, sodium phosphate monobasic monohydrate, water for infection, hydrochloric acid, and sodium hydroxide to adjust its pH (6.5 -7.3). Its recommended use is one drop in the affected eye. The solution should be protected from light and stored at 20° - 25°C (68°-77°F). The manufacturer is Apotex Corp located in Toronto, Ontario, Canada.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
